HSA recalls Metformin ER tablets
The US Food and Drug Administration (FDA) has recommended voluntary recall of certain extended-release (ER) versions of metformin after testing revealed a contaminant in these products. The HSA, in keeping with this advisory, is recalling all Metformin ER tablets.